NBGNX | VEXPX | NBGNX / VEXPX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 36 years | 57 years | - |
Gain YTD | -2.271 | -0.661 | 344% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 9.89B | 22.9B | 43% |
Annual Yield % from dividends | 0.04 | 0.48 | 8% |
Returns for 1 year | 3.97 | 0.58 | 683% |
Returns for 3 years | -1.94 | 3.23 | -60% |
Returns for 5 years | 6.07 | 6.78 | 90% |
Returns for 10 years | -2.34 | 17.94 | -13% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
OPER | 100.39 | 0.04 | +0.04% |
ClearShares Ultra-Short Maturity ETF | |||
AOA | 79.10 | -0.76 | -0.95% |
iShares Core 80/20 Aggressive Allc ETF | |||
AUSF | 43.32 | -0.54 | -1.23% |
Global X Adaptive US Factor ETF | |||
IBRN | 25.34 | -0.37 | -1.42% |
iShares Neuroscience and Healthcare ETF | |||
CCRV | 20.52 | -0.32 | -1.54% |
iShares® Commodity Curve Carry Strat ETF |